Navigation Links
Astellas Confirms Interim Analysis in PREVAIL Study of XTANDI will Occur within Calendar Year 2013
Date:8/1/2013

ed in 3% of XTANDI patients and 2% on placebo. One percent of XTANDI patients compared to 0.3% on placebo died from infections or sepsis. Falls or injuries related to falls occurred in 4.6% of XTANDI patients vs 1.3% on placebo. Falls were not associated with loss of consciousness or seizure. Fall-related injuries were more severe in XTANDI patients and included non-pathologic fractures, joint injuries, and hematomas. Grade 1 or 2 hallucinations occurred in 1.6% of XTANDI patients and 0.3% on placebo, with the majority on opioid-containing medications at the time of the event.

Drug Interactions- Effect of Other Drugs on XTANDI: Administration of strong CYP2C8 inhibitors can increase the plasma exposure to XTANDI. Co-administration of XTANDI with strong CYP2C8 inhibitors should be avoided if possible. If co-administration of XTANDI cannot be avoided, reduce the dose of XTANDI. Co-administration of XTANDI with strong or moderate CYP3A4 and CYP2C8 inducers can alter the plasma exposure of XTANDI and should be avoided if possible.

Effect of XTANDI on Other Drugs: XTANDI is a strong CYP3A4 inducer and a moderate CYP2C9 and CYP2C19 inducer in humans. Avoid CYP3A4, CYP2C9 and CYP2C19 substrates with a narrow therapeutic index, as XTANDI may decrease the plasma exposures of these drugs. If XTANDI is co-administered with warfarin (CYP2C9 substrate), conduct additional INR monitoring.

For Full Prescribing Information, please visit www.XtandiHCP.com.


'/>"/>
SOURCE Astellas Pharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Astellas Appoints New Senior Vice President of Global Oncology Development
2. Dr. Helen Fisher to Speak at Astellas Presents Executive Womens Day at the Constellation SENIOR PLAYERS Championship
3. Molly Fletcher to Speak at Astellas Presents Executive Womens Day at the AT&T National
4. Astellas Signs Distribution Agreement With Tecnofarma For Enzalutamide In Latin America
5. Molly Fletcher to Speak at Astellas Presents Executive Womens Day at the FedEx St. Jude Classic
6. Amgen And Astellas Announce Japan Alliance
7. Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen
8. Astellas Joins the National Pharmaceutical Council
9. Astellas and Gift of Hope Organ & Tissue Donor Network Join Forces to Raise Awareness of Need for More Organ Donors in Illinois
10. Astellas and Gift of Hope Organ & Tissue Donor Network Join Forces to Raise Awareness of Need for More Organ Donors in Chicago
11. Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... LifeNet Health plans to enlarge its workforce ... more than 160 people. The organization,s growth ... innovative bio-implants, which are being made more widely available ... It also is a reflection of the region,s growing ... and success of LifeNet Health is a great example ...
(Date:5/29/2015)... 2015  Haemonetics Corporation (NYSE: HAE ) announced ... will present at the JMP Securities Life Sciences Conference ... 23 rd , 2015 at 11:30am Eastern time.  ... live via webcast at: http://wsw.com/webcast/jmp27/hae ... is a global healthcare company dedicated to providing innovative ...
(Date:5/29/2015)... , May 29, 2015 Amgen (NASDAQ: ... two pivotal Phase 3, global, randomized, placebo-controlled trials ... treatment of secondary hyperparathyroidism (SHPT) in patients with ... met the primary endpoint, demonstrating that a greater ... achieved a greater than 30 percent reduction in ...
Breaking Medicine Technology:LifeNet Health to add more than 160 jobs in 2015 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7
... Sagent Pharmaceuticals, Inc., a privately held specialty ... Drug Administration had granted tentative approval of adenosine injection, ... 60 mg per 20 mL and 90 mg per ... U.S. innovator market for these adenosine presentations approximated ...
... XIANYANG, China , ... Bulletin Board: BSPM) ("Biostar" or "the Company"),a Xianyang-based ... Aoxing Oleanolic Acid Capsules ("Xin Aoxing"), and a ... was approved by,NASDAQ to list its common stock ...
Cached Medicine Technology:Sagent Pharmaceuticals Announces U.S. FDA Tentative Approval of Additional Adenosine Injection, USP Vial Presentations 2Biostar Pharmaceuticals Approved for Listing on NASDAQ Global Market 2Biostar Pharmaceuticals Approved for Listing on NASDAQ Global Market 3Biostar Pharmaceuticals Approved for Listing on NASDAQ Global Market 4
(Date:5/29/2015)... (PRWEB) May 29, 2015 Abington ... be among the first hospitals in the nation ... enhance maternity care practices and work toward achieving ... hospital-based quality-improvement initiative focusing on maternity care practices ... for Disease Control and Prevention, EMPower is aimed ...
(Date:5/29/2015)... Angeles, CA (PRWEB) May 29, 2015 The ... greatly in the last decade. New and more efficient methods ... hair available to balding patients. One of the most cutting ... Parsa Mohebi Hair Restoration is the technique of extracting hair ... to scalp transplants are performed to correct male pattern ...
(Date:5/29/2015)... Port Richey, FL (PRWEB) May 29, 2015 ... that nearly one in 10 full-time workers has a substance ... and 2012 from more than 111,500 adults with full-time jobs, ... alcohol disorder in the previous year. (1) The National Council ... employers $81 billion per year, and an estimated 70% of ...
(Date:5/29/2015)... May 29, 2015 Red Hot & ... newest Red Hot & Blue restaurant at 525 New Waverly ... May 7, 2015. “The Red Hot & Blue Restaurant was ... years, but we have moved to a new location in ... the middle of all the activities on the Promenade–with outdoor ...
(Date:5/29/2015)... May 29, 2015 To compile the ... choosing systems that have several awards for clinical and ... what systems stood out to them in terms of ... as well. , The 50 Great Health Systems to ... Health System (Altamonte Springs, Fla.) , Advocate Health Care ...
Breaking Medicine News(10 mins):Health News:Abington Hospital Selected to Join Baby-Friendly Hospital Initiative 2Health News:Beard to Scalp Hair Transplant: Newest Advance in Hair Transplant Technology 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 3Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 4Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 3Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 4Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 2Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 3
... whose parents have high expectations for their ability to ... other children dealing with the condition, according to a ... asthma controller medications appropriately if they have a routine ... how well symptoms can be controlled. , The study, ...
... many calories they are actually consuming, which can hinder ... person would overestimate the amount of exercise they,re doing, ... a study to be presented at The Obesity Society,s ... a Lead Health Services Specialist at Temple,s Center for ...
... Food and Drug,Administration (FDA) reopened discussions on ... dispensing decongestants, antihistamines and cough,suppressants to children, ... the,estimated benefits for children based on using ... in adults., (Photo: http://www.newscom.com/cgi-bin/prnh/20081003/NEF040-a ...
... Discrimination; Recognizes,Importance of Mental Health to Overall ... Mental Health,America today hailed as "a great ... health parity legislation that will broadly outlaw ... and substance-use,conditions in employer-sponsored health plans., ...
... As the population ages, a big,question employers must start asking ... In most cases the answer is no. 95% of ... provide for their families. What,happens when one of the spouses ... drops for the person that is sick but the healthy,employee/spouse ...
... General surgeon salary survey shows 40 percent imagine negative income impact. ... ... Although the economy currently dominates both the news media and the ... for the new president, according to recent survey results. But how ...
Cached Medicine News:Health News:Children's asthma affected by parental expectations 2Health News:Safe New Children's Medicines Launched for Cough, Cold and Flu Season 2Health News:Safe New Children's Medicines Launched for Cough, Cold and Flu Season 3Health News:Mental Health America Hails Approval of Federal Parity Legislation 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 3Health News:Can Your Employees Survive the Financial Crunch of an Illness? 2Health News:LocumTenens.com Reaps Mixed Reviews on Universal Healthcare 2Health News:LocumTenens.com Reaps Mixed Reviews on Universal Healthcare 3